228 related articles for article (PubMed ID: 27117535)
1. Cervical esophageal cancer: a gap in cancer knowledge.
Hoeben A; Polak J; Van De Voorde L; Hoebers F; Grabsch HI; de Vos-Geelen J
Ann Oncol; 2016 Sep; 27(9):1664-74. PubMed ID: 27117535
[TBL] [Abstract][Full Text] [Related]
2. High dose radiation with chemotherapy followed by salvage esophagectomy among patients with locally advanced esophageal squamous cell carcinoma.
Lertbutsayanukul C; Tharavej C; Klaikeaw N; Prayongrat A; Lowanitchai C; Sriuranpong V
Thorac Cancer; 2017 May; 8(3):219-228. PubMed ID: 28322515
[TBL] [Abstract][Full Text] [Related]
3. Comparison between chemoselection and definitive radiotherapy in patients with cervical esophageal squamous cell carcinoma.
Nakata Y; Hanai N; Nishikawa D; Suzuki H; Koide Y; Fukuda Y; Nomura M; Kodaira T; Shimizu T; Hasegawa Y
Int J Clin Oncol; 2017 Dec; 22(6):1034-1041. PubMed ID: 28623448
[TBL] [Abstract][Full Text] [Related]
4. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy for Cervical Esophageal Squamous Cell Carcinoma.
Kwong DLW; Chan WWL; Lam KO
Methods Mol Biol; 2020; 2129():295-305. PubMed ID: 32056186
[TBL] [Abstract][Full Text] [Related]
6. Re-evaluating the optimal radiation dose for definitive chemoradiotherapy for esophageal squamous cell carcinoma.
He L; Allen PK; Potter A; Wang J; Chang JY; Gomez DR; Komaki R; Liao Z; Lin SH
J Thorac Oncol; 2014 Sep; 9(9):1398-405. PubMed ID: 25122435
[TBL] [Abstract][Full Text] [Related]
7. [Concurrent chemoradiation with paclitaxel and platinum for locally advanced esophageal cancer].
Zhang P; Xie CY; Wu SX
Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):773-7. PubMed ID: 18396692
[TBL] [Abstract][Full Text] [Related]
8. [A case of advanced esophageal carcinoma successfully treated with chemoradiation therapy with low-dose cisplatin and 5-fluorouracil].
Oyama K; Hirosawa H; Ito H; Fukushima W; Masutani H; Kadoya N; Izumi R; Hirono T
Gan To Kagaku Ryoho; 2000 Jun; 27(6):899-903. PubMed ID: 10897218
[TBL] [Abstract][Full Text] [Related]
9. Comparison of cisplatinum/paclitaxel with cisplatinum/5-fluorouracil as first-line therapy for nonsurgical locally advanced esophageal squamous cell carcinoma patients.
Hu G; Wang Z; Wang Y; Zhang Q; Tang N; Guo J; Liu L; Han X
Drug Des Devel Ther; 2016; 10():2129-36. PubMed ID: 27445460
[TBL] [Abstract][Full Text] [Related]
10. Esophageal cancer located at the neck and upper thorax treated with concurrent chemoradiation: a single-institution experience.
Wang S; Liao Z; Chen Y; Chang JY; Jeter M; Guerrero T; Ajani J; Phan A; Swisher S; Allen P; Cox JD; Komaki R
J Thorac Oncol; 2006 Mar; 1(3):252-9. PubMed ID: 17409865
[TBL] [Abstract][Full Text] [Related]
11. Role of concomitant chemoradiation in locally advanced head and neck cancers.
Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
[TBL] [Abstract][Full Text] [Related]
12. The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy.
Chen YH; Lu HI; Lo CM; Wang YM; Chou SY; Hsiao CC; Huang CC; Shih LH; Chen SW; Li SH
BMC Cancer; 2018 Aug; 18(1):837. PubMed ID: 30126380
[TBL] [Abstract][Full Text] [Related]
13. Definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced cervical esophageal cancer.
Okamoto H; Taniyama Y; Sakurai T; Heishi T; Teshima J; Sato C; Maruyama S; Ito K; Onodera Y; Konno-Kumagai T; Ishida H; Kamei T
Esophagus; 2018 Oct; 15(4):281-285. PubMed ID: 29948480
[TBL] [Abstract][Full Text] [Related]
14. Radiation therapy and esophageal cancer.
Shridhar R; Almhanna K; Meredith KL; Biagioli MC; Chuong MD; Cruz A; Hoffe SE
Cancer Control; 2013 Apr; 20(2):97-110. PubMed ID: 23571700
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of concurrent chemoradiotherapy and erlotinib for inoperable esophageal squamous cell carcinoma.
Zhao C; Lin L; Liu J; Liu R; Chen Y; Ge F; Jia R; Jin Y; Wang Y; Xu J
Oncotarget; 2016 Aug; 7(35):57310-57316. PubMed ID: 28087951
[TBL] [Abstract][Full Text] [Related]
16. Toxicity of chemotherapy for esophageal carcinoma.
Ilson D
Chest Surg Clin N Am; 1997 Aug; 7(3):551-63; discussion 564. PubMed ID: 9246402
[TBL] [Abstract][Full Text] [Related]
17. [Multimodality management of squamous cell carcinoma of thoracic esophagus].
Wang ZX; Mao T; Guo XF; Fang WT
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):815-8. PubMed ID: 24061983
[TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity.
Haefner MF; Lang K; Verma V; Koerber SA; Uhlmann L; Debus J; Sterzing F
Radiat Oncol; 2017 Aug; 12(1):131. PubMed ID: 28810885
[TBL] [Abstract][Full Text] [Related]
19. Dose escalation intensity-modulated radiotherapy-based concurrent chemoradiotherapy is effective for advanced-stage thoracic esophageal squamous cell carcinoma.
Chang CL; Tsai HC; Lin WC; Chang JH; Hsu HL; Chow JM; Yuan KS; Wu ATH; Wu SY
Radiother Oncol; 2017 Oct; 125(1):73-79. PubMed ID: 28923576
[TBL] [Abstract][Full Text] [Related]
20. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.
Hejna M; Kornek GV; Schratter-Sehn AU; Zach M; Schoder M; Raderer M; Rosen H; Schiessel R; Scheithauer W
Cancer; 1996 Oct; 78(8):1646-50. PubMed ID: 8859175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
